Geron Corp. (GERN): Short Seller Sentiment is Bearish on This Cancer Stock

By Yahoo! Finance | Sep 14, 2024 at 05:13 PM EST

The article discusses the growing global burden of cancer, advancements in cancer treatment, and the potential of Geron Corp. as a cancer therapy developer. Despite being among the worst cancer stocks according to short sellers, Geron has promising prospects in the field of oncology.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.